ScholarIQanswers from OpenAlex

Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis

PaperCitations, authors & open-access status

Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis have?

ScholarIQcitation count

Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis has 453 citations in the OpenAlex counts ScholarIQ stores.

When was Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis published?

ScholarIQyear

Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis has 2010 year in the ScholarIQ index.

What is the open-access status of Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis?

ScholarIQoa status

Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis has green oa status in the ScholarIQ index.

What is the DOI of Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis?

ScholarIQdoi

The DOI for Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis is on the source record.

What is the PMID of Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis?

ScholarIQpmid

The PMID for Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis is on the source record.

What is the OpenAlex record for Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis?

ScholarIQopenalex

The OpenAlex for Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial